– UAE, Abu Dhabi – Al Noor Hospitals Group, Plc (ANH.L) announces that, as part of its succession plan, Dr. Kassem Alom, Chief Executive Officer will be vacating the post of Chief Executive and stepping down as an Executive Director of the Company on 1 October 2014. On that date, he will be appointed Non-Executive Deputy Chairman of the Company, initially to ensure a smooth handover of responsibilities to the new Chief Executive, and then to provide support to the Company as needed.
The Board of Al Noor is delighted to announce the appointment of Ronald Lavater as Chief Executive of the Company with effect from 1 October 2014. Mr. Lavater, a US citizen, joins from Johns Hopkins Medicine International (JHI), a well-respected global healthcare company, where he is currently serving as a Senior Executive for the Middle East Region. From 2009 through 2013, Ronald was Chief Executive Officer of the JCI accredited Corniche Hospital in Abu Dhabi, the largest maternity and neo-natal hospital in the UAE.
Prior to JHI, Mr. Lavater worked for 12 years with Hospital Corporation of America (HCA), the US’s largest NYSE listed hospital company, and held several hospital leadership roles including Chief Executive Officer and Chief Operating Officer.
Mr. Lavater holds a bachelor’s degree in political science from the University of Florida and a master’s degree in public administration from Florida State University. Mr. Lavater is a Fellow with the American College of Healthcare Executives (ACHE) and is serving a two-year term as president of the Middle East & North Africa ACHE group.
Ian Tyler, Chairman of Al Noor said: “Dr. Alom founded Al Noor in 1985 and has led the growth of the Company from a single clinic into the largest private hospital group in the Emirate of Abu Dhabi. We are delighted that he will stay with the Company as Deputy Chairman, initially to ensure a smooth handover of responsibilities, and that we will continue to benefit from his experience and his strong relationships with key stakeholders.
“The Board is very pleased to welcome Ronald Lavater as the Company’s new Chief Executive Offer. He brings significant experience, gained from within the UAE and the United States. His track record as Chief Executive of major hospitals is impressive and the Board is looking forward to working with him to grow Al Noor for the benefit of our patients and wider stakeholders.”
Dr. Kassem Alom said: “I am very pleased with the appointment of Ronald as our Chief Executive. We set a very high bar when we embarked on the search for my successor, and I am confident that Ronald has the right experience, energy, and character to take Al Noor through the next phase of growth. He has my full confidence, and I stand ready to support him and Al Noor as needed in my new role as Deputy Chairman.”
Ronald Lavater said: “I am honoured to be selected to lead Al Noor Hospitals Group and continue to build on the Company’s strong reputation for excellence in patient care, created by Dr. Alom. I am also very much looking forward to working with the Board, management and employees to take full advantage of the exceptional growth opportunities that lie ahead.”
About Al Noor
Al Noor Hospitals Group plc, the largest private hospital group in the Emirate of Abu Dhabi, provides a wide range of medical and surgical services through various hospitals, clinics, and pharmacies. It operates three hospitals with 224 operational beds and an outpatient medical centres network covering a wide portion of the population of the Emirate of Abu Dhabi. Al Noor is the only private healthcare provider in the Emirate of Abu Dhabi that is capable of providing extensive geographic coverage in the three key regions of the Emirate. It occupies a leading position in the inpatient as well as outpatient market. Al Noor also operates a clinic in the Sultanate of Oman.
The company is listed in on the London Stock Exchange (ticker: ANH.L).
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
